Capital Research Global Investors Buys 136,260 Shares of The Ensign Group, Inc. $ENSG

Capital Research Global Investors lifted its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 7.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 2,016,101 shares of the company’s stock after acquiring an additional 136,260 shares during the quarter. Capital Research Global Investors’ holdings in The Ensign Group were worth $348,322,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. CWM LLC grew its position in The Ensign Group by 8.4% during the third quarter. CWM LLC now owns 732 shares of the company’s stock valued at $126,000 after buying an additional 57 shares during the period. Profund Advisors LLC raised its holdings in The Ensign Group by 2.5% during the 3rd quarter. Profund Advisors LLC now owns 2,378 shares of the company’s stock valued at $411,000 after acquiring an additional 59 shares during the period. UMB Bank n.a. lifted its holdings in The Ensign Group by 7.3% during the 3rd quarter. UMB Bank n.a. now owns 911 shares of the company’s stock worth $157,000 after purchasing an additional 62 shares in the last quarter. HB Wealth Management LLC lifted its holdings in shares of The Ensign Group by 4.1% in the third quarter. HB Wealth Management LLC now owns 1,810 shares of the company’s stock worth $313,000 after buying an additional 72 shares in the last quarter. Finally, Campbell Newman Asset Management Inc. boosted its holdings in The Ensign Group by 0.4% in the 3rd quarter. Campbell Newman Asset Management Inc. now owns 19,480 shares of the company’s stock valued at $3,366,000 after purchasing an additional 79 shares during the period. 96.12% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on ENSG shares. Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the company a “hold” rating in a research report on Friday, February 6th. UBS Group set a $230.00 target price on shares of The Ensign Group and gave the stock a “buy” rating in a report on Friday, February 6th. Zacks Research upgraded shares of The Ensign Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 26th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, The Ensign Group has a consensus rating of “Buy” and a consensus target price of $204.60.

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $209.65 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.42 and a quick ratio of 1.42. The company has a market capitalization of $12.14 billion, a PE ratio of 35.90, a PEG ratio of 2.06 and a beta of 0.83. The Ensign Group, Inc. has a 1-year low of $118.73 and a 1-year high of $218.00. The business has a fifty day moving average price of $192.08 and a 200-day moving average price of $182.23.

The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.75 by $0.07. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same period last year, the firm posted $1.49 earnings per share. The Ensign Group’s revenue was up 20.2% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. As a group, equities analysts expect that The Ensign Group, Inc. will post 5.59 EPS for the current fiscal year.

The Ensign Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Saturday, January 31st. Stockholders of record on Wednesday, December 31st were issued a $0.065 dividend. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. This is a boost from The Ensign Group’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend was Wednesday, December 31st. The Ensign Group’s payout ratio is presently 4.45%.

Insiders Place Their Bets

In other news, Director Barry M. Smith sold 700 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $213.02, for a total transaction of $149,114.00. Following the sale, the director directly owned 22,852 shares of the company’s stock, valued at $4,867,933.04. This represents a 2.97% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John O. Agwunobi sold 146 shares of the company’s stock in a transaction that occurred on Wednesday, January 21st. The shares were sold at an average price of $178.31, for a total value of $26,033.26. Following the sale, the director owned 9,087 shares in the company, valued at approximately $1,620,302.97. This trade represents a 1.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 27,473 shares of company stock worth $5,167,422. 3.90% of the stock is owned by corporate insiders.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.